Selenium intakes and type-2 diabetes

In many regions of the world, it may not be possible to get an optimal amount of selenium from meals. The content of selenium in our food depends on the availability of selenium in the soil. Known selenium-poor areas are found in much of Europe and the Middle East, China, Korea, Japan, and New Zealand. In the United States, the coastal areas tend to have lower selenium content than the middle of the country does.

In 2013, Dr. Margaret Rayman, University of Surrey, United Kingdom, reviewed the published reports of randomized controlled trials in which a selenium supplement had been used as a single-agent treatment option and in which there had been a follow-up or sub-group analysis of the effect of the selenium supplementation on the risk of type-2 diabetes.

Dr. Rayman found 5 such studies.  I want to summarize Dr. Rayman’s review, and then I want to see what studies have been done since 2013.

Selenium and diabetes studies
Nutritional Prevention of Cancer (NPC) study
In 2007, Dr. Saverio Stranges published the results of a post hoc analysis of the data from the Nutritional Prevention of Cancer study.  In the NPC study, supplementation for an average of 4.5 years with 200 micrograms of a high selenium yeast preparation resulted in significant reductions in the risk of lung cancer, colon cancer, and prostate cancer [Clark 1996].  The age of most participants in the study was 63 years, plus or minus 10 years. read more

Selenium and HIV and opportunistic infections

Individuals infected by the human immunodeficiency virus (HIV) that causes acquired immunodeficiency syndrome (AIDS) commonly have low selenium status. Selenium supplementation can prevent or delay the decline of immune system function and can protect against opportunistic infections.

Selenium supplements – especially selenium supplements as a component of a multi-micronutrient cocktail – can help to delay the decline of the immune system and can reduce the risk of death in HIV-infected patients.  Most of the data that we have comes from randomized controlled studies carried out in African countries, but the results are relevant to the United States and Europe.  Moreover, the results from studies of HIV-infected patients speak to the issue of the anti-microbial protection and antioxidant protection that comes with adequate selenium status.

Selenium and HIV and CD4 counts
CD4 cells are white blood cells that are part of the immune system.  Specifically, the CD4 cells fight infections in the body.  The HIV virus kills CD4 cells.  When a person has fewer CD4 cells, he or she is at greater risk of contracting an infection. read more

Selenium and the risk of pre-eclampsia

Pre-eclampsia is a serious condition that causes high blood pressure in pregnant women who did not have high blood pressure prior to their pregnancies. The high blood pressure typically develops after the 20th week of pregnancy. Research studies show that a daily selenium supplement can reduce the risk of pre-eclampsia.

There is a clear relationship between a pregnant woman’s selenium status and her risk of pre-eclampsia.   Observational studies show that low selenium status is associated with a greater risk of pre-eclampsia.  Studies of selenium supplementation have shown reduced incidence of pre-eclampsia [Xu].

What is pre-eclampsia?
Pre-eclampsia is a complex condition characterized by the onset, around week 20 of the pregnancy, of the following symptoms:

  • abnormally high protein levels in the urine (indicating possible damage to the kidneys)
  • systolic blood pressure greater than 140 mmHg or diastolic blood pressure greater than 90 mmHg when measured twice with an interval of at least 4–6 hours and not more than 7 days apart [Uzan]
  • severe headaches
  • blurred vision
  • decreased platelet levels in the blood [Mayo Clinic]

Pre-eclampsia seems to be caused by an abnormal development of the new blood vessels that are needed to carry blood to the placenta.  The new blood vessels are narrower than they should be, and they respond differently to hormonal signaling [Mayo Clinic]. read more